Recombinant methioninase effectively targets a Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.
about
Is DNA methylation the new guardian of the genome?Patient-Derived Orthotopic Xenograft (PDOX) Models of Melanoma.Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model.Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and prevention.The wayward methyl group and the cascade to cancer.The combination of temozolomide-irinotecan regresses a doxorubicin-resistant patient-derived orthotopic xenograft (PDOX) nude-mouse model of recurrent Ewing's sarcoma with a FUS-ERG fusion and CDKN2A deletion: Direction for third-line patient therapIndividualized doxorubicin sensitivity testing of undifferentiated soft tissue sarcoma (USTS) in a patient-derived orthotopic xenograft (PDOX) model demonstrates large differences between patients.Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: Decoy, trap and kill chRecombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse models.Genetic and metabolic comparison of orthotopic and heterotopic patient-derived pancreatic-cancer xenografts to the original patient tumors.Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.Intra-tumor L-methionine level highly correlates with tumor size in both pancreatic cancer and melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse models.Recombinant methioninase combined with doxorubicin (DOX) regresses a DOX-resistant synovial sarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model.Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model
P2860
Q39233074-ACD9F6FE-E3C3-4C13-B7BD-443051423278Q41661119-35641D1B-EB43-438E-89FE-53FE543FDE24Q46198099-C844A680-0C4F-4FA3-9AF1-F1029A2C2A32Q46341637-03BC69F4-9FA6-4F01-AA5A-782E0ECC4545Q46570903-D1364F14-2EE7-4F32-AD20-E7415164C206Q47105755-0EFA30EB-2F68-4C0F-91DC-A04353CA1BF3Q48135854-AD6DA0EA-DF96-45FB-8B59-F846281A5757Q48156221-8B4FB669-D3A8-4FFB-BE1D-4338ACA69F16Q49185022-09355772-A443-41C1-A111-08AB703CD445Q50353132-BB96F56F-4F17-45E9-8AB8-E6D078CE80BCQ52603159-632B6795-31AF-44CC-8B4C-FC94D392AC0CQ52655050-C3EBCA68-A4EB-4B35-BCDA-021EC62BE252Q55076815-16AE6A5C-1699-4170-AA59-922F0B110885Q58736789-37D6D85C-3BB2-4C2D-B695-E93A3DD91AC9
P2860
Recombinant methioninase effectively targets a Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Recombinant methioninase effec ...... graft (PDOX) nude-mouse model.
@ast
Recombinant methioninase effec ...... graft (PDOX) nude-mouse model.
@en
type
label
Recombinant methioninase effec ...... graft (PDOX) nude-mouse model.
@ast
Recombinant methioninase effec ...... graft (PDOX) nude-mouse model.
@en
prefLabel
Recombinant methioninase effec ...... graft (PDOX) nude-mouse model.
@ast
Recombinant methioninase effec ...... graft (PDOX) nude-mouse model.
@en
P2093
P2860
P50
P356
P1433
P1476
Recombinant methioninase effec ...... graft (PDOX) nude-mouse model.
@en
P2093
Arun S Singh
Fritz C Eilber
Itaru Endo
Jonathan C DeLong
Kei Kawaguchi
Kentaro Igarashi
Kuniya Tanaka
Michael Bouvet
Qinghong Han
Robert M Hoffman
P2860
P304
35630-35638
P356
10.18632/ONCOTARGET.15823
P407
P577
2017-03-01T00:00:00Z